Allergy Therapeutics
AGY.L
#6145
Rank
A$1.32 B
Marketcap
A$0.22
Share price
-6.82%
Change (1 day)
93.75%
Change (1 year)

Earnings for Allergy Therapeutics (AGY.L)

Earnings in 2025: -A$77.12 Million

According to Allergy Therapeutics's latest financial reports the company's current earnings are A$75.57 Million. In 2025 the company made an earning of -A$77.12 Million a decrease over its 2024 earnings that were of -A$70.99 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Allergy Therapeutics from 2002 to 2025

Annual earnings

Year Earnings Change
2025-A$77.12 Million8.65%
2024-A$70.99 Million-6.69%
2023-A$76.08 Million244.94%
2022-A$22.06 Million-404.35%
2021A$7.24 M-49.42%
2020A$14.32 M83.48%
2019A$7.8 M-159.83%
2018-A$13.06 Million255.48%
2017-A$3.68 Million-84.06%
2016-A$23.04 Million-1667.33%
2015A$1.46 M-44.68%
2014A$2.65 M130.59%
2013A$1.15 M-19.89%
2012A$1.43 M-127.05%
2011-A$5.32 Million2009.96%
2010-A$0.26 Million-99.07%
2009-A$27.01 Million-53.23%
2008-A$57.74 Million-21.86%
2007-A$73.89 Million356.94%
2006-A$16.18 Million230.75%
2005-A$4.89 Million-217.9%
2004A$4.14 M-58.79%
2003A$10.06 M-196.03%
2002-A$10.48 Million